Publications by authors named "Markus Letsch"

Claim this Profile
T
The worst case: giant exulcerating seminoma.
Markus Letsch, Martin Spahn, Matthias Beissert, Max S Topp, Elmar W Gerharz

Urol Int· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
Marta Zarandi, Jozsef L Varga, Andrew V Schally, Judit E Horvath, Gabor L Toller, Markus Letsch

Proc Natl Acad Sci U S A· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.
Anton Stangelberger, Andrew V Schally, Markus Letsch, Karoly Szepeshazi, Attila Nagy

Int J Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238.
Markus Letsch, Andrew V Schally, Karoly Szepeshazi, Gabor Halmos, Attilla Nagy

J Urol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Markus Letsch, Andrew V Schally, Karoly Szepeshazi, Gabor Halmos, Attila Nagy

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.
Markus Letsch, Andrew V Schally, Rebeca Busto, Ana M Bajo, Jozsef L Varga

Proc Natl Acad Sci U S A· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Artur Plonowski, Andrew V Schally, Markus Letsch, Magdalena Krupa, Francine Hebert

Prostate· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis